{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:20:35Z","timestamp":1781871635300,"version":"3.54.5"},"reference-count":36,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2023,7,29]]},"DOI":"10.1536\/ihj.22-715","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T22:13:45Z","timestamp":1690582425000},"page":"741-749","source":"Crossref","is-referenced-by-count":6,"title":["Yixin Granules Reduce Myocardial Inflammation and Fibrosis in Rats with Heart Failure by Inhibiting the Expression of ADAMTS8"],"prefix":"10.1536","volume":"64","author":[{"given":"Jianhua","family":"Li","sequence":"first","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtai","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Heart Disease, Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Orso F, Fabbri G, Maggioni AP. Epidemiology of heart failure. Handb Exp Pharmacol 2017; 243: 15-33.","DOI":"10.1007\/164_2016_74"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Heidenreich PA, Bozkurt B, Aguilar D, <i>et al<\/i>. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e895-1032.","DOI":"10.1161\/CIR.0000000000001073"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kurmani S, Squire I. Acute heart failure: Definition, classification and epidemiology. Curr Heart Fail Rep 2017; 14: 385-92.","DOI":"10.1007\/s11897-017-0351-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tomasoni D, Adamo M, Lombardi CM, Metra M. Highlights in heart failure. ESC Heart Fail 2019; 6: 1105-27.","DOI":"10.1002\/ehf2.12555"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol 2020; 17: 269-85.","DOI":"10.1038\/s41569-019-0315-x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gonzalez A, Schelbert EB, Diez J, Butler J. Myocardial interstitial fibrosis in heart failure: Biological and translational perspectives. J Am Coll Cardiol 2018; 71: 1696-706.","DOI":"10.1016\/j.jacc.2018.02.021"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Huang C, Qiu S, Fan X, <i>et al<\/i>. Evaluation of the effect of Shengxian Decoction on doxorubicin-induced chronic heart failure model rats and a multicomponent comparative pharmacokinetic study after oral administration in normal and model rats. Biomed Pharmacother 2021; 144: 112354.","DOI":"10.1016\/j.biopha.2021.112354"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Santamaria S, Martin DR, Dong X, Yamamoto K, Apte SS, Ahnstrom J. Post-translational regulation and proteolytic activity of the metalloproteinase ADAMTS8. J Biol Chem 2021; 297: 101323.","DOI":"10.1016\/j.jbc.2021.101323"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Schooling CM, Luo S, Johnson G. ADAMTS-13 activity and ischemic heart disease: a Mendelian randomization study. J Thromb Haemost 2018; 16: 2270-5.","DOI":"10.1111\/jth.14267"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wunnemann F, Ta-Shma A, Preuss C, <i>et al<\/i>. Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. Nat Genet 2020; 52: 40-7.","DOI":"10.1038\/s41588-019-0536-2"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Li H, Zhou Y, Song W, Li J, Xu J. Expression of ADAMTS-1 mRNA in myocardium of viral heart disease mice and its clinical significance. Exp Ther Med 2019; 17: 153-8.","DOI":"10.3892\/etm.2018.6894"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Omura J, Satoh K, Kikuchi N, <i>et al<\/i>. ADAMTS8 promotes the development of pulmonary arterial hypertension and right ventricular failure: A possible novel therapeutic target. Circ Res 2019; 125: 884-906.","DOI":"10.1161\/CIRCRESAHA.119.315398"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Badoer E. New insights into the role of inflammation in the brain in heart failure. Front Physiol 2022; 13: 837723.","DOI":"10.3389\/fphys.2022.837723"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Wang A, Zhao W, Yan K, <i>et al<\/i>. Mechanisms and efficacy of traditional Chinese medicine in heart failure. Front Pharmacol 2022; 13: 810587.","DOI":"10.3389\/fphar.2022.810587"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Normand C, Kaye DM, Povsic TJ, Dickstein K. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology. Lancet 2019; 393: 1045-55.","DOI":"10.1016\/S0140-6736(18)32216-5"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bacmeister L, Schwarzl M, Warnke S, <i>et al<\/i>. Inflammation and fibrosis in murine models of heart failure. Basic Res Cardiol 2019; 114: 19.","DOI":"10.1007\/s00395-019-0722-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Li S, Nong Y, Gao Q, <i>et al<\/i>. Astragalus granule prevents Ca<sup>2+<\/sup> current remodeling in heart failure by the downregulation of CaMKII. Evid Based Complement Alternat Med 2017; 2017: 7517358.","DOI":"10.1155\/2017\/7517358"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cao Y, Shen T, Huang X, <i>et al<\/i>. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Oncotarget 2017; 8: 4837-48.","DOI":"10.18632\/oncotarget.13596"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shi H, Zhou P, Gao G, <i>et al<\/i>. Astragaloside IV prevents acute myocardial infarction by inhibiting the TLR4\/MyD88\/NF-\u03baB signaling pathway. J Food Biochem 2021; 45: e13757.","DOI":"10.1111\/jfbc.13757"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zhao Y, Liu Z, Zhang H. Astragaloside protects myocardial cells from apoptosis through suppression of the TLR4\/NF-\u03baB signaling pathway. Exp Ther Med 2018; 15: 1505-9.","DOI":"10.3892\/etm.2017.5535"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Liu T, Zhang M, Niu H, <i>et al<\/i>. Astragalus polysaccharide from Astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4\/NF-\u03baB p65 signal pathway and protects mice from CVB3-induced virus myocarditis. Int J Biol Macromol 2019; 126: 179-86.","DOI":"10.1016\/j.ijbiomac.2018.12.207"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Xing N, Wang Y, Wang W, <i>et al<\/i>. Cardioprotective effect exerted by Timosaponin BII through the regulation of endoplasmic stress-induced apoptosis. Phytomedicine 2020; 78: 153288.","DOI":"10.1016\/j.phymed.2020.153288"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hao W, Shi Y, Qin Y, <i>et al<\/i>. Platycodon grandiflorum protects against anthracycline-induced cardiotoxicity in early breast cancer patients. Integr Cancer Ther 2020; 19: 1534735420945017.","DOI":"10.1177\/1534735420945017"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lin YC, Lin CH, Yao HT, <i>et al<\/i>. Platycodon grandiflorum (PG) reverses angiotensin II-induced apoptosis by repressing IGF-IIR expression. J Ethnopharmacol 2017; 205: 41-50.","DOI":"10.1016\/j.jep.2017.04.028"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lin YC, Lin YC, Kuo WW, <i>et al<\/i>. Platycodin D reverses pathological cardiac hypertrophy and fibrosis in spontaneously hypertensive rats. Am J Chin Med 2018; 46: 537-49.","DOI":"10.1142\/S0192415X18500271"},{"key":"26","unstructured":"26. Yao J, Zhang H, Ma L, <i>et al<\/i>. Effect of traditional Chinese medicine Bupleurum in the treatment of influenza A (H1N1). Pak J Pharm Sci 2018; 31: 1713-7."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Morvaridzadeh M, Qorbani M, Shokati Eshkiki Z, <i>et al<\/i>. The effect of almond intake on cardiometabolic risk factors, inflammatory markers, and liver enzymes: A systematic review and meta-analysis. Phytother Res 2022; 36: 4325-44.","DOI":"10.1002\/ptr.7622"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ren J, Fu L, Nile SH, Zhang J, Kai G. Salvia miltiorrhiza in treating cardiovascular diseases: A review on its pharmacological and clinical applications. Front Pharmacol 2019; 10: 753.","DOI":"10.3389\/fphar.2019.00753"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Cui XH, Wang HL, Wu R, Yao PA, Wei KZ, Gao JP. Effect of Atractylodes macrocephala rhizoma on isoproterenol-induced ventricular remodeling in rats. Mol Med Rep 2018; 17: 2607-13.","DOI":"10.3892\/mmr.2017.8121"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Peng L, Lei Z, Rao Z, <i>et al<\/i>. Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia\/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis. Phytomedicine 2021; 93: 153798.","DOI":"10.1016\/j.phymed.2021.153798"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Zha Y, Li Y, Ge Z, <i>et al<\/i>. ADAMTS8 promotes cardiac fibrosis partly through activating EGFR dependent pathway. Front Cardiovasc Med 2022; 9: 797137.","DOI":"10.3389\/fcvm.2022.797137"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Li L, Yuan S, Zhao X, Luo T. ADAMTS8 is frequently down-regulated in colorectal cancer and functions as a tumor suppressor. Biochem Biophys Res Commun 2020; 524: 663-71.","DOI":"10.1016\/j.bbrc.2020.01.020"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wu Z, Shi Y, Ren S, Ju Y, Hu Y, Wu J. ADAMTS8 inhibits progression of esophageal squamous cell carcinoma. DNA Cell Biol 2020; 39: 2300-7.","DOI":"10.1089\/dna.2020.6053"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Zhang K, Tian R, Wang G, <i>et al<\/i>. ADAMTS8 inhibits cell proliferation and invasion, and induces apoptosis in breast cancer. Onco Targets Ther 2020; 13: 8373-82.","DOI":"10.2147\/OTT.S248085"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhao X, Yang C, Wu J, Nan Y. ADAMTS8 targets ERK to suppress cell proliferation, invasion, and metastasis of hepatocellular carcinoma. Onco Targets Ther 2018; 11: 7569-78.","DOI":"10.2147\/OTT.S173360"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Badshah II, Brown S, Weibel L, <i>et al<\/i>. Differential expression of secreted factors SOSTDC1 and ADAMTS8 cause profibrotic changes in linear morphoea fibroblasts. Br J Dermatol 2019; 180: 1135-49.","DOI":"10.1111\/bjd.17352"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/4\/64_22-715\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T04:01:48Z","timestamp":1690603308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/64\/4\/64_22-715\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,29]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.22-715","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,29]]},"article-number":"22-715"}}